Name | af38469 |
---|---|
Synonyms | 2-[(6-methylpyridin-2-yl)carbamoyl]-5-(trifluoromethyl)benzoic acid |
Description | AF38469 is a novel, selective, orally bioavailable Sortilin inhibitor with an IC50 value of 330 nM. |
---|---|
Related Catalog | |
Target |
IC50:330 nM (Sortilin)[1] |
In Vitro | AF38469 showed no inhibition or stimulation of >50% at 10 μM in a standard selectivity panel of ca. 70 targets run at CEREP. Importantly AF38469 showed no activity against the NTR1 receptor. In addition AF38469 showed no activity against a selected panel of targets known to bind acidic molecules (d-Opioid, GPR40, PPARd, EP1, Angiotensin AT1, Endothelin ETA & B, MMP-12). AF38469 will serve as an important tool to further delineate the biology of Sortilin, and to facilitate evaluation of the therapeutic potential of this protein[1]. |
References |
Molecular Formula | C15H11F3N2O3 |
---|---|
Molecular Weight | 324.25500 |
Exact Mass | 324.07200 |
PSA | 79.29000 |
LogP | 3.43230 |
Storage condition | 2-8℃ |